- Who We Are
- Updates & News
- Standards
- Software Tools
- Network Studies
- Community Forums
- Education
- New To OHDSI?
- Community Calls
- Past Events
- 2024 India Symposium
- 2024 Europe Symposium
- 2024 Thailand Tutorial
- 2024 Japan Tutorial
- 2024 DevCon
- 2024 Phenotype Phebruary
- 2023 Global Symposium
- 2023 APAC Symposium
- 2023 Europe Symposium
- 2023 SOS Challenge
- 2023 DevCon
- 2023 Phenotype Phebruary
- 2022 Global Symposium
- 2021 Global Symposium
- 2020 Global Symposium
- ALL Past OHDSI Events
- Workgroups
- 2024 ‘Our Journey’ Annual Report
- Current OHDSI Events
- Support & Sponsorship
- CBER Best Seminars
- 2024 Global Symposium
- 2024 APAC Symposium
- Github
- YouTube
- Newsletters
OHDSI APAC - Our Asia-Pacific Community
OHDSI is a global, multi-stakeholder, interdisciplinary and open-science network that collaborates to bring out the value of health data through large-scale analytics. Our Asia-Pacific (APAC) community comprises seven regional chapters (Australia, China, India, Japan, Singapore, South Korea, Taiwan) and has led important OHDSI initiatives around the world.
OHDSI APAC Community in Teams
The APAC community has its own group in the OHDSI MS Teams environment to promote greater collaboration on our collaborative efforts. First, request access to our MS Teams Environment, then request access to our OHDSI APAC workgroup.
APAC Community Meetings
Everybody is invited to our regular community meetings. APAC Community Calls are held monthly every third Thursday at 12 pm Korea time, while APAC Scientific Forums are held monthly every first Thursday at 12 pm Korea time in our Microsoft Teams environment. In these regular meetings, we provide updates from the community and ongoing studies, host mini-tutorials and walkthroughs on the community’s areas of interest, conduct ad hoc discussions and brainstorming, and plenty more. The upcoming schedule is available in the graphic above.
Use this link to get to the APAC Community Calls and this link to get to the APAC Scientific Forums. The recordings from all 2024 (and 2023) calls will be posted here; recordings from 2021-2022 calls are available here.
Ongoing APAC Studies
We currently have three ongoing studies in the APAC community. If you are interested to participate or contribute, please reach out to the study owners!
- Characterization of health by OHDSI AP chapter to identify temporal effect of the pandemic (CHAPTER) – by Seng Chan You (seng.chan.you@ohdsi.org)
- Comparison of mortality, morbidities & healthcare resources utilization between patients with and without a diagnosis of COVID-19 – by Celine Chui (cceline@connect.hku.hk), Shirley Li (sxueli@hku.hk), Eric Wan (yfwan@hku.hk)
- Treatment, utilization and safety of medicines for multiple sclerosis (TELEMUS) and incidence of progressive multifocal leukoencephalopathy (PML) during multiple sclerosis biologic exposure – by Nicole Pratt (nicole.pratt@unisa.edu.au), Thamir M. Alshammari (thamer.alshammary@gmail.com)
Study documents and meeting recordings are saved under each study channel in OHDSI APAC Teams.
Past APAC Events
The 2023 APAC Symposium was held July 13-14 in Sydney, Australia at the University of New South Wales. Under the overarching theme of A collaborative recipe for generating reliable real-world evidence, the symposium consisted of a one-day conference featuring exciting lectures, panel discussions, lightning talks, poster presentations and networking sessions, and a full-day tutorial walking through the entire lifecycle of generating reliable evidence using the OHDSI ecosystem. If you missed the event, recordings are available on the symposium homepage.
The 2022 APAC Symposium returned to an in-person setting at the Taipei Medical University. It included main presentations on Envisioning of OHDSI Global & OHDSI APAC; The Implication Experiences in OHDSI Region; and The Challenges of Research in OHDSI APAC. The symposium also included a full-day tutorial. All slides and recordings have been posted on the symposium homepage.
The 2021 OHDSI Symposium featured a set of presentations including the State of the Global and APAC Community, the EHDEN Consortium and the FHIR/OHDSI collaboration, study sessions, workgroup meetings and a collaborator showcase.
There was also a 2021 APAC ETL Training Tutorial, which included seven sessions: Introduction to ETL & Source Data Analysis, Vocabulary Mapping Part I, Vocabulary Mapping Part II, ETL Specification Writing, ETL Specification Review, Common Issues in ETL Conversion and OMOP ETL Development, and Data Quality Checks. You can watch all of the recordings now on the tutorial homepage.
The first OHDSI APAC Symposium provided an opportunity for our Asia-Pacific collaborators to share research, updates, and network discussions. The meeting recordings are saved in 2020 APAC Symposium Teams.
Regional Chapters: Australia | China | India | Japan | Korea | Taiwan | Singapore
- 2024 OHDSI APAC Symposium News
- Community-wide ETL Project: Project Closeout
Video Presentation
- 2024 OHDSI APAC Symposium News
- OHDSI India Symposium 2024
- Community-wide ETL Project Status Update
- Medical Imaging Workgroup by Kyulee Jeon
Video Presentation
- 2024 OHDSI APAC Symposium News
- Community-wide ETL Project: Sprint 3 Review
Video Presentation
- 2024 OHDSI APAC Symposium News
- OHDSI Evidence Network
- Oncology Workgroup Introduction and Updates by Asieh Golozar
Video Presentation
- OHDSI News
- European Symposium Recap by Taipei Medical University Team
- Community-wide ETL Project
Video Presentation
- AI-based Prediction for Post-Surgical Complications in Patients Undergoing Elective Surgery by Singapore A*STAR
Video Presentation
- OHDSI News
- Regional Chapter Mid-Year Updates
- Taiwan by Jason C. Hsu
- Korea by Seng Chan You
- Japan by Keiko Asao
- Australia by Nicole Pratt
- China by Lei Liu
- Singapore by Mengling ‘Mornin’ Feng
Video Presentation
- OHDSI News
- Recaps/Reflections of OHDSI/OMOP Events in April
- OMOP Introductory Tutorial in Thailand by Natthawut ‘Max’ Adulyanukosol
- OHDSI Japan Event by Yoshihiro Aoyagi and Seng Chan You
- OMOP Lecture in Taiwan by Jason Hsu
- April Olympians by Jiawei Qian
Video Presentation
- OHDSI News
- CaRROT-Mapper Introduction and Demo by Esmond Urwin
- Re-executing an Outdated OHDSI R Package by Mengyuan Shang
Video Presentation
- April OHDSI/OMOP Events in APAC
- Enabling Genotyping Data Capture in OMOP CDM: Case Study of GUSTO GDM Cohort by Singapore A*STAR
Video Presentation
- OHDSI News: April Olympians by Clair Blacketer
- OHDSI Evidence Network by Clair Blacketer
- Vocabulary Contribution from Korea by Seng Chan You
- Upcoming OHDSI/OMOP Events in APAC
Video Presentation
- STEMI Network Study Introduction by Atif Adam
- Perseus Introduction and Demonstration by Anton Ivano
Video Presentation
- OHDSI News
- New Workgroup Introductions
- Industry (Mui Van Zandt)
- Evidence Translation (Nicole Pratt)
Video Presentation
- Results of survey on support areas
- Plans for 2024 Q1
- APAC study updates
Video Presentation
- APAC 2024 Kickoff
- Training Session #7 by Japan
- Eye Care and Vision Research WG Intro
Video Presentation
- OHDSI News
- Community Contribution to the OHDSI Standardized Vocabularies (Part 3) by Anna Ostropolets
Video Presentation
- OHDSI News
- Global Symposium Recap
- From Singapore by Mukkesh Kumar and Cindy Ho
- From Taiwan by Septi Melisa and Dian Tri Wiyanti
- Training Session #6 by Taiwan
- Population level estimation study: Risk of cardiovascular disease among female cancer patients using hormone therapies by Whitney Burton
- Patient level prediction study: Prediction of dementia among patients with chronic disease by Thanh-Phuc Phan, Daniel Chris, Sunny Lin
Video Presentation
- OHDSI News
- Medicinal Cannabis Study Overview by Christine Hallinan
- Data Quality of OHDSI APAC: CDM Inspection Study Update & Deep Learning Comparison Study Overview by Chungsoo Kim
- December Meeting Preview
- Support Areas Follow-up Survey Extension
Video Presentation
- OHDSI News
- Support Areas Follow-up Survey
- Call for Volunteers: Multiple Sclerosis Study
- Call for Collaborators: Medicinal Cannabis Study by Christine Hallinan
- Community Contribution to the OHDSI Standardized Vocabularies (Part 2) by Anna Ostropolets
Video Presentation
- OHDSI News
- Training Session #5: Multiple Sclerosis
- Characterization: incidence of progressive multifocal leukoencephalopathy (PML) during Multiple Sclerosis (MS) biologic exposure by Thamir M. Alshammari
- Treatment, utilisation and safety of medicines for Multiple Sclerosis (TELEMUS) by Nicole Pratt
Video Presentation
- Support Areas Follow-up Survey
- OMOP CDM Survey 2023
- Community Contribution to the OHDSI Standardized Vocabularies by Anna Ostropolets
Video Presentation
- OHDSI News
- India Chapter Mid-Year Update by Swetha Kiran
- European Symposium Recap by Chungsoo Kim
- APAC Symposium Recap by Nicole Pratt and Sujeong Eom
Video Presentation
- OHDSI News
- Regional Chapter Mid-Year Updates
- Taiwan by Jason Hsu
- China by Lei Liu
- Australia by Nicole Pratt
- Japan by Tatsuo Hiramatsu
- Singapore by Mengling Feng
- Korea by Rae Woong Park
Video Presentation
- OHDSI News
- Training Session #4: A*STAR Data Vault: a research platform for the Singapore ecosystem and beyond (Mukkesh Kumar and Cindy Ho)
Video Presentation
- OHDSI News
- Training Session #2: Conducting comparative effectiveness study using CohortMethod Package by Seng Chan You and Subin Kim
Video Presentation
- OHDSI News
- Training Session #1: How to utilize CohortDiagnostics Package to evaluate cohort definitions? by Xiaoyu Lin
- Call for Participation
Video Presentation
- Future Directions of OHDSI
- 2022 Goals Recap and 2023 Goals
- Community Calls Restructure
- APAC Scientific Forum
- 2023 OHDSI APAC Symposium
Video Presentation
By the end of the month, collaborators identified and reviewed 93 clinical studies, developed an ATLAS and CohortDiagnostics demo, built and publicly shared 30 cohort definitions, and created three shiny apps with full cohort diagnostics on results.ohdsi.org.
The OHDSI community has engaged in Phenotype Phebruary in both 2022 and 2023, and this year the community set a goal to understand what is the current practices in the field and how much researchers introduce variability in the process of phenotype development and evaluation.
